Myelitis  >>  Omr-IgG-am (intravenous normal human immunoglobulin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Omr-IgG-am (intravenous normal human immunoglobulin) / J&J
NCT00069316: Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease

Completed
2
2
US
Omr-IgG-am
National Institutes of Health Clinical Center (CC)
West Nile Virus
06/07
06/07
NCT00068055: IVIG - West Nile Encephalitis: Safety and Efficacy

Completed
1/2
62
US, Canada
Omr-lgG-am, Polygam® S/D, Placebo
National Institute of Allergy and Infectious Diseases (NIAID)
West Nile Virus
12/06
12/06

Download Options